AlloVir Inc (ALVR)
0.7505
+0.01
(+1.42%)
USD |
NASDAQ |
Apr 19, 15:57
AlloVir Shareholders Equity (Quarterly): 145.78M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 145.78M |
| September 30, 2023 | 195.33M |
| June 30, 2023 | 229.11M |
| March 31, 2023 | 193.53M |
| December 31, 2022 | 224.52M |
| September 30, 2022 | 253.23M |
| June 30, 2022 | 158.14M |
| March 31, 2022 | 191.68M |
| December 31, 2021 | 225.27M |
| Date | Value |
|---|---|
| September 30, 2021 | 267.30M |
| June 30, 2021 | 302.47M |
| March 31, 2021 | 330.37M |
| December 31, 2020 | 353.06M |
| September 30, 2020 | 373.90M |
| June 30, 2020 | -71.29M |
| March 31, 2020 | 113.11M |
| December 31, 2019 | -51.50M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-71.29M
Minimum
Jun 2020
373.90M
Maximum
Sep 2020
202.00M
Average
224.52M
Median
Dec 2022
Shareholders Equity (Quarterly) Benchmarks
| Arcutis Biotherapeutics Inc | 88.67M |
| CEL-SCI Corp | 12.65M |
| AIM ImmunoTech Inc | 10.23M |
| IGC Pharma Inc | 9.053M |
| NovaBay Pharmaceuticals Inc | 3.314M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 190.80M |
| Total Liabilities (Quarterly) | 45.02M |